Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma.
Adenocarcinoma
/ epidemiology
Barrett Esophagus
/ epidemiology
Biomarkers, Tumor
/ genetics
Case-Control Studies
Esophageal Neoplasms
/ epidemiology
Eye Proteins
/ genetics
Female
Gastroesophageal Reflux
/ epidemiology
Genetic Loci
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Male
Obesity
/ epidemiology
Polymorphism, Single Nucleotide
RNA-Binding Proteins
/ genetics
Risk Assessment
Risk Factors
Serine Endopeptidases
/ genetics
Sex Factors
Barrett’s esophagus
Genome-Wide Association Study
Interaction
Sex Difference
Journal
Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
03
05
2020
revised:
04
08
2020
accepted:
24
08
2020
pubmed:
13
9
2020
medline:
16
4
2021
entrez:
12
9
2020
Statut:
ppublish
Résumé
Esophageal adenocarcinoma (EA) and its premalignant lesion, Barrett's esophagus (BE), are characterized by a strong and yet unexplained male predominance (with a male-to-female ratio in EA incidence of up to 6:1). Genome-wide association studies (GWAS) have identified more than 20 susceptibility loci for these conditions. However, potential sex differences in genetic associations with BE/EA remain largely unexplored. Given strong genetic overlap, BE and EA cases were combined into a single case group for analysis. These were compared with population-based controls. We performed sex-specific GWAS of BE/EA in 3 separate studies and then used fixed-effects meta-analysis to provide summary estimates for >9 million variants for male and female individuals. A series of downstream analyses were conducted separately in male and female individuals to identify genes associated with BE/EA and the genetic correlations between BE/EA and other traits. We included 6758 male BE/EA cases, 7489 male controls, 1670 female BE/EA cases, and 6174 female controls. After Bonferroni correction, our meta-analysis of sex-specific GWAS identified 1 variant at chromosome 6q11.1 (rs112894788, KHDRBS2-MTRNR2L9, P The identified novel sex-specific variants associated with BE/EA could improve the understanding of the genetic architecture of the disease and the reasons for the male predominance.
Sections du résumé
BACKGROUND & AIMS
Esophageal adenocarcinoma (EA) and its premalignant lesion, Barrett's esophagus (BE), are characterized by a strong and yet unexplained male predominance (with a male-to-female ratio in EA incidence of up to 6:1). Genome-wide association studies (GWAS) have identified more than 20 susceptibility loci for these conditions. However, potential sex differences in genetic associations with BE/EA remain largely unexplored.
METHODS
Given strong genetic overlap, BE and EA cases were combined into a single case group for analysis. These were compared with population-based controls. We performed sex-specific GWAS of BE/EA in 3 separate studies and then used fixed-effects meta-analysis to provide summary estimates for >9 million variants for male and female individuals. A series of downstream analyses were conducted separately in male and female individuals to identify genes associated with BE/EA and the genetic correlations between BE/EA and other traits.
RESULTS
We included 6758 male BE/EA cases, 7489 male controls, 1670 female BE/EA cases, and 6174 female controls. After Bonferroni correction, our meta-analysis of sex-specific GWAS identified 1 variant at chromosome 6q11.1 (rs112894788, KHDRBS2-MTRNR2L9, P
CONCLUSIONS
The identified novel sex-specific variants associated with BE/EA could improve the understanding of the genetic architecture of the disease and the reasons for the male predominance.
Identifiants
pubmed: 32918910
pii: S0016-5085(20)35130-1
doi: 10.1053/j.gastro.2020.08.052
pmc: PMC9057456
mid: NIHMS1627421
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Eye Proteins
0
KHDRBS2 protein, human
0
Prss55 protein, human
0
RNA-Binding Proteins
0
RP1L1 protein, human
0
Serine Endopeptidases
EC 3.4.21.-
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2065-2076.e1Subventions
Organisme : NCI NIH HHS
ID : K05 CA124911
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034987
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK063616
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA091955
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA136725
Pays : United States
Organisme : NIDDK NIH HHS
ID : R21 DK077742
Pays : United States
Investigateurs
Jing Dong
(J)
Carlo Maj
(C)
Spiridon Tsavachidis
(S)
Quinn T Ostrom
(QT)
Puya Gharahkhani
(P)
Lesley A Anderson
(LA)
Anna H Wu
(AH)
Weimin Ye
(W)
Leslie Bernstein
(L)
Oleg Borisov
(O)
Julia Schröder
(J)
Wong-Ho Chow
(WH)
Marilie D Gammon
(MD)
Geoffrey Liu
(G)
Carlos Caldas
(C)
Paul D Pharoah
(PD)
Harvey A Risch
(HA)
Andrea May
(A)
Christian Gerges
(C)
Mario Anders
(M)
Marino Venerito
(M)
Thomas Schmidt
(T)
Jakob R Izbicki
(JR)
Arnulf H Hölscher
(AH)
Brigitte Schumacher
(B)
Yogesh Vashist
(Y)
Horst Neuhaus
(H)
Thomas Rösch
(T)
Michael Knapp
(M)
Peter Krawitz
(P)
Anne Böhmer
(A)
Prasad G Iyer
(PG)
Brian J Reid
(BJ)
Jesper Lagergren
(J)
Nicholas J Shaheen
(NJ)
Douglas A Corley
(DA)
Ines Gockel
(I)
Rebecca C Fitzgerald
(RC)
Michael B Cook
(MB)
David C Whiteman
(DC)
Thomas L Vaughan
(TL)
Johannes Schumacher
(J)
Aaron P Thrift
(AP)
Informations de copyright
Copyright © 2020 AGA Institute. All rights reserved.
Références
Mod Pathol. 2009 Feb;22(2):261-72
pubmed: 18953328
Brain. 2019 Sep 1;142(9):2581-2589
pubmed: 31497858
Mol Neurobiol. 2017 Dec;54(10):8021-8032
pubmed: 27878761
Lancet Oncol. 2016 Oct;17(10):1363-1373
pubmed: 27527254
Breast Cancer. 2014 Nov;21(6):715-23
pubmed: 23381229
Ann Oncol. 2017 Mar 1;28(3):604-610
pubmed: 27993815
Clin Gastroenterol Hepatol. 2016 Mar;14(3):338-347.e1
pubmed: 26484704
Clin Cancer Res. 2017 May 1;23(9):2335-2345
pubmed: 28151721
J Biol Chem. 2000 Apr 28;275(17):13000-6
pubmed: 10777602
Acta Neuropathol. 2018 Dec;136(6):857-872
pubmed: 29967939
J Natl Cancer Inst. 2019 Jan 1;111(1):34-41
pubmed: 29788475
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4631-E4640
pubmed: 28533408
PLoS Comput Biol. 2015 Apr 17;11(4):e1004219
pubmed: 25885710
Nat Commun. 2018 May 8;9(1):1825
pubmed: 29739930
Am J Epidemiol. 2005 Dec 1;162(11):1050-61
pubmed: 16221805
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):427-433
pubmed: 31748258
Mol Cancer Res. 2010 Sep;8(9):1198-206
pubmed: 20736295
Am J Transl Res. 2015 Jul 15;7(7):1271-9
pubmed: 26328011
Dig Dis Sci. 2018 Aug;63(8):1988-1996
pubmed: 29671158
BMC Cancer. 2015 Nov 10;15:885
pubmed: 26555036
J Natl Cancer Inst. 2013 Nov 20;105(22):1711-8
pubmed: 24168968
Am J Gastroenterol. 2020 Feb;115(2):216-223
pubmed: 31658123
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Onco Targets Ther. 2018 Feb 14;11:781-789
pubmed: 29497310
Mol Neurobiol. 2018 May;55(5):4403-4416
pubmed: 28660485
Int J Cancer. 2013 May 1;132(9):1986-95
pubmed: 23023514
PLoS One. 2010 Dec 30;5(12):e16010
pubmed: 21209860
J Biol Chem. 2008 Apr 4;283(14):9399-413
pubmed: 18218617
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Nat Rev Gastroenterol Hepatol. 2015 Apr;12(4):243-8
pubmed: 25666644
Clin Gastroenterol Hepatol. 2016 Mar;14(3):330-2
pubmed: 26528803
Am Heart J. 2002 Aug;144(2):212-8
pubmed: 12177636
Nucleic Acids Res. 2012 Jan;40(Database issue):D930-4
pubmed: 22064851
PLoS One. 2018 Jan 17;13(1):e0190325
pubmed: 29342161
Nat Genet. 2012 Mar 18;44(4):369-75, S1-3
pubmed: 22426310
Nat Rev Genet. 2008 Dec;9(12):911-22
pubmed: 19002143
Nat Rev Genet. 2019 Mar;20(3):173-190
pubmed: 30581192
Gut. 2009 Feb;58(2):182-8
pubmed: 18978173
PLoS One. 2014 Jul 30;9(7):e103508
pubmed: 25075959
Gastroenterology. 2015 Feb;148(2):367-78
pubmed: 25447851
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Gastroenterology. 2018 Apr;154(5):1273-1281.e3
pubmed: 29247777
Sci Rep. 2015 Sep 02;5:13750
pubmed: 26330360
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Gastroenterol Clin North Am. 2016 Dec;45(4):615-624
pubmed: 27837776
Nat Rev Cancer. 2009 Mar;9(3):182-94
pubmed: 19194382
Gut. 2015 Mar;64(3):381-7
pubmed: 25320104
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Cancer Causes Control. 2005 Apr;16(3):285-94
pubmed: 15947880
JAMA Netw Open. 2018 Aug;1(4):e181670
pubmed: 30294719
Nat Genet. 2013 Dec;45(12):1487-93
pubmed: 24121790
Nat Commun. 2017 Nov 28;8(1):1826
pubmed: 29184056
Ann Oncol. 2012 Dec;23(12):3155-3162
pubmed: 22847812
Nat Genet. 2012 Oct;44(10):1131-6
pubmed: 22961001
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
BMC Cancer. 2015 Apr 12;15:272
pubmed: 25884948
PLoS Genet. 2012;8(12):e1003098
pubmed: 23284291
Br J Cancer. 2010 Aug 24;103(5):735-40
pubmed: 20700121
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894
pubmed: 30371827
Br J Cancer. 2008 Nov 4;99(9):1506-10
pubmed: 18841152
Bioinformatics. 2017 Jan 15;33(2):272-279
pubmed: 27663502
Clin Gastroenterol Hepatol. 2015 Apr;13(4):673-82
pubmed: 25158929
Genet Epidemiol. 2010 Sep;34(6):591-602
pubmed: 20718045
Sci Rep. 2018 May 9;8(1):7352
pubmed: 29743610
Gastroenterology. 2012 Apr;142(4):744-53
pubmed: 22245667
Cold Spring Harb Perspect Med. 2012 May;2(5):a006627
pubmed: 22553494
Nature. 2007 Jun 7;447(7145):661-78
pubmed: 17554300
Biomed Pharmacother. 2020 Jan;121:109562
pubmed: 31707341
J Natl Cancer Inst. 2010 Sep 8;102(17):1344-53
pubmed: 20716718
Gut. 2017 Oct;66(10):1739-1747
pubmed: 27486097
Nat Genet. 2018 Oct;50(10):1412-1425
pubmed: 30224653
Am J Gastroenterol. 2013 Jun;108(6):915-22
pubmed: 23567358
Gut. 2013 Dec;62(12):1684-91
pubmed: 23355549
J Exp Clin Cancer Res. 2018 Sep 15;37(1):228
pubmed: 30219064
Nat Cell Biol. 2002 Aug;4(8):583-91
pubmed: 12134159
PLoS One. 2019 Dec 31;14(12):e0227072
pubmed: 31891614
Oncotarget. 2016 Jun 21;7(25):38876-38883
pubmed: 27145283
Cancer Res. 2005 Jun 1;65(11):4587-97
pubmed: 15930276
Biochem Biophys Res Commun. 2010 Feb 12;392(3):252-7
pubmed: 19995558
Gastroenterology. 2018 Jan;154(2):390-405
pubmed: 28780073
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2177-82
pubmed: 20080664
Genet Epidemiol. 2011 Jan;35(1):11-8
pubmed: 21181894
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Int J Mol Med. 2018 May;41(5):2755-2763
pubmed: 29436606
Nat Genet. 2007 Jul;39(7):906-13
pubmed: 17572673
PLoS One. 2011 May 05;6(5):e19297
pubmed: 21573214
Genet Epidemiol. 2010 Dec;34(8):846-53
pubmed: 21104887
Nat Methods. 2011 Dec 04;9(2):179-81
pubmed: 22138821
Int J Epidemiol. 2012 Dec;41(6):1706-18
pubmed: 23148106
Nat Genet. 2019 Feb;51(2):237-244
pubmed: 30643251
Drug Metab Rev. 2011 May;43(2):300-6
pubmed: 21495795
Cell Death Dis. 2019 Jan 15;10(2):33
pubmed: 30674889